Pharmaceuticals, Biotechnology and Life Sciences
Company Announcement COPENHAGEN, Denmark; April 13, 2021 – Genmab A/S (Nasdaq: GMAB) Following Genmab A/S’ Annual General Meeting held on…
SAN DIEGO, April 13, 2021 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty…
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 13, 2021 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives…
Maryland-based physicians can quickly deploy remote care options for patients with PRA’s digital health technologyRALEIGH, N.C. and BALTIMORE, April 13,…
UPPSALA, SWEDEN – The shareholders of LIDDS AB (publ), corp. ID no. 556580-2856, are invited to the Annual General Meeting…
On track to initiate Phase 1 trials for four wholly owned drug candidates in 2021 Expanded Sanofi collaboration resulting in…
04_13_2021 PR Image An Example of NFT Tauri-Gum™ Art Content The Company’s Newly Formed Division Will be Called: NFTauriga Corp.…
Press ReleaseNicox: 2021 Ordinary and Extraordinary General Meetings postponed to April 28, 2021 April 13, 2021 Sophia Antipolis, France Nicox…
Company announcement – No. 21/ 2021 Boehringer Ingelheim and Zealand Pharma Advance to Phase 2 Clinical Testing in NASH and…
EAST SETAUKET, New York, April 13, 2021 (GLOBE NEWSWIRE) — Lixte Biotechnology Holdings, Inc. (“Lixte” or the “Company”) (Nasdaq: LIXT),…